| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |